Improve Cancer-related Cognitive Impairment
Recruiting
N/A
Interventional Study
Gynecologic Cancer
Chemotherapy Effect
Chemo-brain
Cancer-related Cognitive Difficulties
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
At a Glance
- Age
- 18 – 90
- Sex
- Female
- Study type
- Interventional
- Purpose
- Health Services Research
- Participants needed
- 64 (estimated)
- Sponsor
- University of Alabama at Birmingham · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Cancer-related cognitive impairment (CRCI), also known as "chemobrain," is the cognitive decline that negatively impacts the majority of cancer patients undergoing chemotherapy, radiation, and/or hormonal treatments. This application focuses on evaluating if using a cognitive mobile training application can decrease the impact of CRCI in gynecologic oncology patients through a multidisciplinary ap…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion criteria are:
* newly diagnosed gynecologic malignancy (uterine, cervical, ovarian, primary peritoneal, vulvar, or vaginal) and undergoing chemotherapy
* own a smartphone or tablet with ability to download cognitive training application
* and age \>21 years old
Exclusion criteria include…
Contacts